Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Robyn S. Maguire
‛Get Us out of This!’: Developing and Implementing an Exit Strategy to Conclude Drug and Device Litigation
BARNES & THORNBURG EMAIL DISCLAIMER Before sending mail to your intended recipient, you must first understand the implications of communicating with Barnes & Thornburg LLP and agree to the following terms. Barnes & Thornburg LLP appreciates your visit to the firm’s web site. Our site is provided for informational purposes only and should not be considered legal advice.
Do You Qualify for Immunity Under the Public Readiness and Preparedness Act? | JD Supra
Updated: May 25, 2018: JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.
Policymakers Grant Tort Immunity to Health Care Providers Developing a Cure for COVID-19 | JD Supra
Updated: May 25, 2018: JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.
Diagnosis: Risk - The Product Liability Challenges of Diagnostic Health Technology
by Robyn S. Maguire and Melanie L. Todman | June 1, 2019 at 6:06 am Health care is on the cusp of a diagnostic revolution. With recent advances in life science technology, researchers and health care entrepreneurs are developing novel digital tools for predicting and preventing disease and, in the process, transforming consumer and patient access to personalized health information. New technology is impacting the diagnosis and treatment of a broad array of medical conditions.
How the FDA’s New 3-D Printing Guidance Informs Product Liability
The Food and Drug Administration recently updated its guidance on the design and manufacturing of 3-D printed medical products. Attorneys at Nutter McClennen & Fish analyze how the guidance will shape product liability law. In December 2017, the Food and Drug Administration issued final guidance applicable to prescription drugs and medical devices manufactured with 3-D printing technology, or additive manufacturing (AM).
Beyond the Parameters of Pre-emption: The Rise of Sales Rep Liability
Robyn S. Maguire is a partner in Nutter McClennen & Fish's litigation department and a member of the firm's product liability and toxic tort litigation and business litigation practice groups. She focuses her practice on complex civil disputes, with an emphasis on drug and medical device and land use litigation cases.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Robyn S.
Contact Robyn S., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack